Le Lézard
Classified in: Business
Subject: ECO

DebtX: CMBS Loan Prices Declined In October


BOSTON, Nov. 29, 2017 /PRNewswire/ -- DebtX, the largest marketplace for loans, said today that prices of commercial real estate loans underlying CMBS fell in October.

DebtX Logo. (PRNewsFoto/DebtX)

During the month, the estimated price of whole loans securing the CMBS universe declined to 97.2% from 98.7% at the end of September 2017. Prices were 99.1% in October 2016.

"CRE loan prices in the CMBS universe have continued their downward trend since mid-summer," said DebtX Managing Director Will Mercer. "Prices declined as Treasuries rose."

As of the end of October, DebtX priced $1.09 trillion in commercial real estate loans that collateralize U.S. CMBS trusts. From last month, the median adjusted loan-to-value remained at 58%, and the median debt service coverage ratio was unchanged at 1.52. The median estimated loan yield increased to 4.3%.

DebtX provides third-party loan valuation services for both public and private clients, as well as analytics and data based on over a decade of secondary market loan sales at DebtX. To learn more, call 617.531.3429 or for information about loan sale advisory services, call 617.531.3400.

About DebtX
DebtX operates the world's most liquid marketplace for loans. Through its loan sale advisory, DebtX maximizes loan sale proceeds for financial institutions and government agencies. DebtX also provides loan valuation, analytics and market data for regulatory and audit purposes. For syndication, agency, and loan sale professionals, DebtX provides a suite of web-based deal management solutions. For loan originators and risk managers, DXScore® is the firm's credit rating system for commercial real estate loans. DebtX is based in Boston, with offices across the U.S., South America, Europe and Asia. Call 617.531.3400 or visit www.debtx.com. Follow DebtX on Facebook, Twitter and LinkedIn.

 

 

 

 

SOURCE DebtX


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:39
Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...

at 19:35
Regenx Tech Corp., (the "Company" or "Regenx") is providing this bi-weekly update on the status of the application to the Alberta Securities Commission for a management cease trade order, under National Policy 12-203 -?? Management Cease Trade...

at 19:14
Kadestone Capital Corp. ("Kadestone" or the "Company") , a vertically integrated property company today announced its financial results for the year ended December 31, 2023....

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...



News published on and distributed by: